Vaccinia virus mutants useful for cancer immunotherapy Grant US-11884939-B2 United States of America 30 Jan 2024
USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (MVA)AS… Application EP-4122492-A1 European Patent Office 25 Jan 2023
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with… Grant US-11541087-B2 United States of America 03 Jan 2023
FLT3 ligand fusion proteins and methods of use Grant US-11542308-B2 United States of America 03 Jan 2023